If you’ve not had a test and have questions about costs or coverage, use our estimator.
If you have already had a test performed, we can help answer questions about results.
Ask questions about genetic testing options or results, or schedule an appointment.
- Wapner RJ, Lese MC, Brynn L, et. al. Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis. N Engl J Med. 2012;No.367(23):2175-2184.
- American College of Obstetricians and Gynecologists. Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162 (2016). Obstet Gynecol. doi: 10.1097/AOG.0000000000001405.
- American College of Obstetricians and Gynecologists. The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis. Committee Opinion No. 581 (2013). Obstet Gynecol. doi: 10.1097/01.AOG.0000438962.16108.d1.
- Yingjun X, Xiaojuan P, Yu D, Huiqun W, Huijuan S. Single Nucleotide Polymorphism-based Microarray Analysis for the Diagnosis of Hydatidiform Moles. Mol Med Rep. 2016; 14(1):137-144. doi: 10.3892/mmr.2016.5211.
- Manning M, and Hudgins L. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12(11):742-5.
- Miller et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764.
- Shen Y, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 2010; 125:e727-35.
- Schwartz S, Burnside R, Gadi I, et al. The impact of microarray studies on prenatal diagnosis: Analysis of 50,000 prenatal samples and 15,000 POCs. Poster presented at: The 10th Philadelphia Prenatal Conference. Jun 6-9, 2018. Philadelphia, PA